Effectiveness and Costs of Molecular Screening and Treatment for Bacterial Vaginosis to Prevent Preterm Birth: The AuTop Randomized Clinical Trial

IMPORTANCE: Bacterial vaginosis (BV) is a well-known risk factor for preterm birth. Molecular diagnosis of BV is now available. Its impact in the screening and treatment of BV during pregnancy on preterm births has not been evaluated to date. OBJECTIVE: To evaluate the clinical and economic effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Bretelle, Florence, Loubière, Sandrine, Desbriere, Raoul, Loundou, Anderson, Blanc, Julie, Heckenroth, Hélène, Schmitz, Thomas, Benachi, Alexandra, Haddad, Bassam, Mauviel, Franck, Danoy, Xavier, Mares, Pierre, Chenni, Nawal, Ménard, Jean-Pierre, Cocallemen, Jean-François, Slim, Nadia, Sénat, Marie Victoire, Chauleur, Céline, Bohec, Caroline, Kayem, Gilles, Trastour, Cynthia, Bongain, André, Rozenberg, Patrick, Serazin, Valerie, Fenollar, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352927/
https://www.ncbi.nlm.nih.gov/pubmed/37459059
http://dx.doi.org/10.1001/jamapediatrics.2023.2250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352927/
https://www.ncbi.nlm.nih.gov/pubmed/37459059
http://dx.doi.org/10.1001/jamapediatrics.2023.2250

Ejemplares similares